Your Location：
Home >
Browse articles >
Multi-Phase Contrast-Enhanced CT Clinical-Radiomics Model for Predicting Prognosis of Extrahepatic Cholangiocarcinoma After Surgery: A Single-Center Retrospective Study
Chinese Medical Sciences Journal   Vol. 40, Issue 3, Pages: 161-170(2025)
Research Article | Updated：2025-10-14

    • Multi-Phase Contrast-Enhanced CT Clinical-Radiomics Model for Predicting Prognosis of Extrahepatic Cholangiocarcinoma After Surgery: A Single-Center Retrospective Study

      Enhanced Publication
    • “In the field of extrahepatic cholangiocarcinoma (eCCA) treatment, a preoperative clinical-radiomics model has been developed and validated to predict overall survival (OS) and disease-free survival (DFS) in patients undergoing radical resection. The model, which includes clinical variables and radiomic features, shows promise as a tool for predicting 1-year OS and DFS in eCCA patients after radical surgery.”

    • DOI：10.24920/004458    

      CLC：

    • Received：24 December 2024，

      Accepted：24 April 2025，

      Published Online：29 September 2025，

      Published：30 September 2025

    Scan QR Code

  • Zhang Shen-Bo,Wang Zheng,Hu Ge,et al.Multi-Phase Contrast-Enhanced CT Clinical-Radiomics Model for Predicting Prognosis of Extrahepatic Cholangiocarcinoma After Surgery: A Single-Center Retrospective Study[J].Chinese Medical Sciences Journal,2025,40(03):161-170. DOI： 10.24920/004458.

  •  
  •  

0

Views

7

Downloads

0

Scopus

PlumX

>
Alert me when the article has been cited
Submit
Outline
No Sections

Related Articles

Cuproptosis-Related 4-Gene Risk Model for Predicting Immunotherapy Drug Response and Prognosis of Kidney Renal Clear Cell Carcinoma
Identifying and Validating a Novel miRNA-mRNA Regulatory Network Associated with Prognosis in Lung Adenocarcinoma
Radiomics in Antineoplastic Agents Development: Application and Challenge in Response Evaluation
Multi-Omics and Its Clinical Application in Hepatocellular Carcinoma: Current Progress and Future Opportunities

Related Author

Zheng-Yu Jin
Zhi-Wei Wang
Si-Hang Cheng
Shen-Bo Zhang
Zheng Wang
Ge Hu
Hao Ding
Peng-Yu Wu

Related Institution

Theranostics and Translational Research Center, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College
Department of Radiology, State Key Laboratory of Complex Severe and Rare Diseases
Department of Radiology, Beijing Chuiyangliu Hospital
Department of General Surgery, the Hospital of Pyongyang Medical University,.P.R.
Department of Breast Surgery, Breast Cancer Key Lab of Dalian, the Second Affiliated Hospital of Dalian Medical University
0